Showing 1 - 9 results of 9 for search 'Bradley C. Carthon', query time: 0.03s
Refine Results
-
1
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [<sup>68</sup>Ga]Ga DOTATATE PET-CT by Mehmet Asim Bilen, Akinyemi Akintayo, Yuan Liu, Olayinka Abiodun-Ojo, Omer Kucuk, Bradley C. Carthon, David M. Schuster, Ephraim E. Parent
Published 2022-12-01
Article -
2
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report by Tony Zibo Zhuang, Lara Harik, Lara Harik, Seth Force, Seth Force, Agreen Hadadi, Mehmet Asim Bilen, Mehmet Asim Bilen, Jacqueline T. Brown, Jacqueline T. Brown, Bradley C. Carthon, Bradley C. Carthon, Jamie Goldman, Jamie Goldman, Omer Kucuk, Omer Kucuk, Viraj A. Master, Viraj A. Master, Bassel Nazha, Bassel Nazha
Published 2022-12-01
Article -
3
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials by Tony Zibo Zhuang, Katherine Case, Timothy Anders Olsen, Jacqueline T. Brown, Bradley C. Carthon, Omer Kucuk, Jamie Goldman, Wayne Harris, Mehmet Asim Bilen, Bassel Nazha
Published 2022-06-01
Article -
4
The Genomic Landscape of Urothelial Carcinoma with High and Low <i>ERBB2</i> Expression by Agreen Hadadi, Harris B. Krause, Andrew Elliott, Jacqueline T. Brown, Bassel Nazha, Lara R. Harik, Bradley C. Carthon, Benjamin Miron, Chadi Nabhan, Pedro C. Barata, Mohamed Saleh, Yuanquan Yang, Rana R. McKay, Mehmet A. Bilen
Published 2023-12-01
Article -
5
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual by Jon A. Hoin, Bradley C. Carthon, Shantoria J. Brown, Lynn M. Durham, L. Crain Garrot, Sharad A. Ghamande, Andrew W. Pippas, Brian M. Rivers, Cindy T. Snyder, Sheryl Gordon Ann Gabram-Mendola, Sheryl Gordon Ann Gabram-Mendola
Published 2024-03-01
Article -
6
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors by Julie M. Shabto, Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E. Hitron, Greta A. Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B. Harris, Viraj A. Master, Omer Kucuk, Bradley C. Carthon, Mehmet A. Bilen
Published 2020-04-01
Article -
7
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience by Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron, Greta Anne Russler, Lauren Yantorni, Sarah Caulfield, Jacqueline T. Brown, Jamie M. Goldman, Bassel Nazha, Bradley C. Carthon, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Published 2022-08-01
Article -
8
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood by Yuan Liu, Haydn Kissick, Viraj A Master, Mehmet A Bilen, Omer Kucuk, Bradley C Carthon, Nataliya Prokhnevska, Ewelina Sobierajska, Rachel Greenwald, Adeboye Osunkoya, Jennifer Wilkinson Carlisle, Caroline S Jansen, Maria Andrea Cardenas, Adriana Moon Reyes, Luke Del Balzo, Patrick Connor Mullane, Deborah Baumgarten, Fares Hosseinzadeh, Scott Wilkinson, Ross Lake, Adam G Sowalsky
Published 2022-07-01
Article -
9
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine
Published 2022-01-01
Article